Although there is no cure for narcolepsy, medication and lifestyle changes can help manage the symptoms. Medicines that ...

Axsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...

In each of these situations, knowledge about the disorder and its treatments may be helpful. For more pervasive anxiety, seeing a therapist or psychologist may be helpful. Since narcolepsy is rare ...

People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

Global Narcolepsy Treatment market to Grow at 5.1% CAGR, Reaching USD 8,718.3 Million by 2034. Key Drivers Include Advanced Drugs, Devices, & Growing Awareness. NEWARK, DE, UNITED STATES ...

Lumryz (sodium oxybate) is a prescription drug used to treat excessive daytime sleepiness or cataplexy from narcolepsy. Lumryz can cause side effects that range from mild to serious. Examples ...

Modafinil is an effective treatment for narcolepsy and excessive sleepiness caused by obstructive sleep apnea, but its efficacy for the treatment of shift-work sleep disorder is not known.

These two leading narcolepsy treatments will be added to our broad and growing CNS portfolio. We will leverage our specialisation and reach to grow these products in existing and new markets ...